Internal Medicine, Endocrinology, Diabetes, & Metabolism · New Haven, CT
NPI
1376885905
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
789 Howard Ave Fl 2
New Haven, CT, 06519
Phone (203) 785-7474
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
841 services
Medicare patients, 2024
475
Average age 72
Drug cost, 2024
$3.2M
550 prescriptions
Company payments, 2023
$13.89
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anika K Anam was code 77080 (standard x-ray), 302 times for 302 patients. In total Anika K Anam billed 841 services in 15 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77080 Standard X-ray | Office | 302 | 302 | $37.69 | $11K |
| 77089 Standard X-ray | Office | 186 | 186 | $31.20 | $5,803 |
| 99214 Office E&M - Established | Facility | 80 | 73 | $74.72 | $5,978 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 26 | $64.02 | $4,033 |
| 77081 Standard X-ray | Office | 56 | 56 | $31.79 | $1,780 |
| 99213 Office E&M - Established | Facility | 42 | 42 | $43.39 | $1,822 |
| 99213 Office E&M - Established | Office | 19 | 15 | $66.02 | $1,254 |
| 99205 Office E&M - New | Facility | 18 | 18 | $137.45 | $2,474 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 18 | 18 | $13.46 | $242 |
| 99214 Office E&M - Established | Office | 17 | 12 | $90.38 | $1,536 |
| 99221 Hospital E&M - Initial | Facility | 12 | 12 | $67.68 | $812 |
| 99204 Office E&M - New | Facility | 11 | 11 | $97.19 | $1,069 |
By year: 2022 $39K for 658 services; 2023 $28K for 478 services; 2024 $39K for 841 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anika K Anam prescribed most often to Medicare patients was Alendronate Sodium, with 145 prescriptions and refills. In total Anika K Anam wrote 550 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 145 | 310 | 39 | $3,193 |
| Synthroid Levothyroxine Sodium | 62 | 176 | 12 | $4,686 |
| Levothyroxine Sodium Generic | 51 | 138 | 19 | $716 |
| Tymlos Abaloparatide | 32 | 46 | Under 11 | $115K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 28 | 61 | 11 | $1,384 |
| Strensiq Asfotase Alfa | 27 | 28 | Under 11 | $2.8M |
| Chlorthalidone Generic | 24 | 70 | Under 11 | $337 |
| Hydrochlorothiazide Generic | 23 | 68 | Under 11 | $129 |
| Risedronate Sodium Generic | 18 | 42 | Under 11 | $436 |
| Calcitriol Generic | 15 | 44 | Under 11 | $353 |
| Crysvita Burosumab-Twza | 11 | 11 | Under 11 | $200K |
Brand drugs: 186 claims; generic drugs: 325 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Anika K Anam $13.89 ($13.89 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $13.89.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $13.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.